Gαi is required for carvedilol-induced β1 adrenergic receptor β-arrestin biased signaling
Open Access
- 22 November 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 8 (1), 1-14
- https://doi.org/10.1038/s41467-017-01855-z
Abstract
The β1 adrenergic receptor (β1AR) is recognized as a classical Gαs-coupled receptor. Agonist binding not only initiates G protein-mediated signaling but also signaling through the multifunctional adapter protein β-arrestin. Some βAR ligands, such as carvedilol, stimulate βAR signaling preferentially through β-arrestin, a concept known as β-arrestin-biased agonism. Here, we identify a signaling mechanism, unlike that previously known for any Gαs-coupled receptor, whereby carvedilol induces the transition of the β1AR from a classical Gαs-coupled receptor to a Gαi-coupled receptor stabilizing a distinct receptor conformation to initiate β-arrestin-mediated signaling. Recruitment of Gαi is not induced by any other βAR ligand screened, nor is it required for β-arrestin-bias activated by the β2AR subtype of the βAR family. Our findings demonstrate a previously unrecognized role for Gαi in β1AR signaling and suggest that the concept of β-arrestin-bias may need to be refined to incorporate the selective bias of receptors towards distinct G protein subtypes.This publication has 51 references indexed in Scilit:
- Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and CarvedilolStructure, 2012
- Multiple ligand-specific conformations of the β2-adrenergic receptorNature Chemical Biology, 2011
- Crystal structure of the β2 adrenergic receptor–Gs protein complexNature, 2011
- Structure and function of an irreversible agonist-β2 adrenoceptor complexNature, 2011
- Teaching old receptors new tricks: biasing seven-transmembrane receptorsNature Reviews Drug Discovery, 2010
- Fine-tuning of GPCR activity by receptor-interacting proteinsNature Reviews Molecular Cell Biology, 2009
- β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivationProceedings of the National Academy of Sciences of the United States of America, 2008
- A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signalingProceedings of the National Academy of Sciences of the United States of America, 2007
- Cardiac GPCRs: GPCR signaling in healthy and failing heartsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006